What does SEMAGLUTIDE | TIRZEPATIDE do to your body?
Both act in the following ways:

Delays how quickly our stomachs digest food. Leading to a feeling of fullness and satisfaction with smaller meal sizes.

Slows intestinal motility so you will feel fuller longer after meals.

GLP-1 Receptor allows for lower blood sugars, in part by reducing the production of sugar in the liver.

Stimulates insulin secretion by the pancreas.

In Tirzepatide GIP increases energy expenditure, resulting in weight loss reductions.

Several effects that can promote weight loss, include:

Reduced appetite: Semaglutide can help to reduce feelings of hunger, which can lead to a decrease in caloric intake.

Slowed gastric emptying: Semaglutide can slow down the rate at which food leaves the stomach, which can help to promote feelings of fullness and satiety.

Increased energy expenditure: Semaglutide can increase the body’s metabolism, leading to an increase in energy expenditure and a decrease in body weight.

What is SEMAGLUTIDE?

Semaglutide is an fda approved weight loss injection (known as Ozempic Brand). By mimicking a hormone in the body by GLP-1 receptor agonist, Semaglutide increases insulin secretion while slowing down how fast your stomach empties food. This suppresses your appetite, so you feel full longer, helping you eat less and lose weight.

Reducing feeling of hunger

Improve quality of life

Improved body composition by reducing excess body fat,

 Reducing abnormal fat abdominal fat averagely 20%

 Increasing the proportion of lean body mass.

Improve blood sugar blood pressure, cholesterol levels, heart disease

What is TIRZEPATIDE?

Tirzepatide is a prescription medicine used for weight loss (Zepbound brand) and type 2 diabetes (Mounjaro brand) in adults. Tirzepatide works for weight loss by decreasing appetite and slowing the movement of food from the stomach into the small intestine, which may make you feel full more quickly and for a longer period of time. In type 2 diabetes, Tirzepatide decreases blood sugar levels by increasing insulin production and lowering the amount of sugar the liver makes. Tirzepatide is a GIP and GLP-1 receptor agonist.

GIP receptor agonists work with your GIP hormone to encourage the production of insulin in your body, as well as increasing sensitivity to insulin itself. 

GLP-1 receptor agonist– when blood sugar levels start to rise after someone eats, these drugs stimulate the body to produce more insulin. The extra insulin helps lower blood sugar levels. 

Both in higher amounts interact with the parts of the brain that reduce appetite and signal a feeling of fullness.